Epidemiological characteristics and access to end-stage liver disease care for HIV-positive patients with HCV and | Zendy

Agata SkrzatKlapaczyńska | Zendy; Bartłomiej Matłosz | Zendy; Dan Oțelea | Zendy; Arjan Harxhi | Zendy; Anna Vassilenko | Zendy; N Bolokadze | Zendy; Kristi Rüütel | Zendy; Antonios Papadopoulos | Zendy; Mariana Märdärescu | Zendy; M Youle | Zendy; Justyna D. Kowalska | Zendy; Andrzej Horban | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Epidemiological characteristics and access to end-stage liver disease care for HIV-positive patients with HCV and

Author(s) -

Agata SkrzatKlapaczyńska,

Bartłomiej Matłosz,

Dan Oțelea,

Arjan Harxhi,

Anna Vassilenko,

N Bolokadze,

Kristi Rüütel,

Antonios Papadopoulos,

Mariana Märdärescu,

M Youle,

Justyna D. Kowalska,

Andrzej Horban

Publication year - 2019

Publication title -

przeglad epidemiologiczny

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.158

H-Index - 18

eISSN - 2545-1898

pISSN - 0033-2100

DOI - 10.32394/pe.73.07

Subject(s) - coinfection , medicine , hepatitis c , liver disease , epidemiology , hepatitis b , liver transplantation , disease , human immunodeficiency virus (hiv) , immunology , transplantation

There is currently an urgent need to harmonize hepatitis standards of care for HIV-positive patients across Europe. The HIV epidemic in Central and Eastern Europe has often been driven by injecting drug use, therefore a higher rate of co-infection with HCV and HBV is expected in this region. We have investigated the epidemiological prevalence and treatment availability for end-stage liver disease in HIV/HCV/HBV coinfections in countries represented in the ECEE Network Group.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research